Good morning :)
Switch to
Place Order

Dr Reddy's Laboratories Ltd

DRREDDY
Health CarePharmaceuticals
LargecapWith a market cap of ₹81,017 cr, stock is ranked 66
Low RiskStock is 1.75x as volatile as Nifty
4,884.5547.40 (-0.96%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
LargecapWith a market cap of ₹81,017 cr, stock is ranked 66
Low RiskStock is 1.75x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
41.51
PB RatioPB Ratio
4.59
Dividend YieldDiv. Yield
0.51%
Sector PESector PE
40.41
Sector PBSector PB
5.41
Sector Div YldSctr Div Yld
0.64%

Forecast & RatingsDetailed Forecast 

81%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Dr. Reddy's Laboratories Limited is a pharmaceutical company that is engaged in providing medicines.

Brands

Dr.Reddy's

Pharmaceutical company

Brands

Dr.Reddy's

Pharmaceutical company

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

201820192020202114.4415.8318.1919.390.951.952.031.95
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Updates 
Announced OnSep 9, 2021

Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'. | Download

Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'. | Download

Press Release 
Announced OnSep 7, 2021

Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated September 07, 2021, titled "Dr. Reddy s launches Minoxidil for women following first-ever approval in India for the treatment of female pattern hair loss.". | Download

Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated September 07, 2021, titled "Dr. Reddy s launches Minoxidil for women following first-ever approval in India for the treatment of female pattern hair loss.". | Download

Cash Dividend 
Ex. DateJul 9, 2021

Final • Div/Share: ₹ 25

See all events